# Lenalidomide In Patients With Acute Myeloid Leukemia

> **NCT00839059** · PHASE1 · TERMINATED · sponsor: **University of Ulm** · enrollment: 14 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** lenalidomide

## Key facts

- **NCT ID:** NCT00839059
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Results of an interim analysis and a hardly ongoing enrolment in the last 10 months in all six participating centres
- **Last updated:** 2011-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00839059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00839059, "Lenalidomide In Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00839059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*